Novel Osteoporosis Medications – Insights from High BMD Disorders

Learn how an increased understanding of the pathophysiology of these disorder gives insight into the development of new targeted osteoporosis therapies.

You will learn:
Artefactual and acquired causes of high BMD
Inherited causes of generalised high BMD
High BMD disorders associated with decreased bone resorption and increased bone deposition
How increased understanding of the pathophysiology of these disorders gives insight into the development of new targeted osteoporosis therapies.

Talk from NOFSA 2021 Virtual Congress Held on 5-7 August 2021

ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report. Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don’t upload these yourself.

To access this module, please register or login:

We are improving our service to you Please will you update your profile now - CLICK HERE
close